These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21197570)

  • 1. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.
    Tamimi RM; Colditz GA; Wang Y; Collins LC; Hu R; Rosner B; Irie HY; Connolly JL; Schnitt SJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):243-50. PubMed ID: 21197570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
    Yang XR; Figueroa JD; Hewitt SM; Falk RT; Pfeiffer RM; Lissowska J; Peplonska B; Brinton LA; Garcia-Closas M; Sherman ME
    Breast Cancer Res Treat; 2013 Feb; 137(3):837-47. PubMed ID: 23271326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
    Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
    Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low activation of Insulin-like Growth Factor 1-Receptor (IGF1R) is associated with local recurrence in early breast carcinoma.
    Peiró G; Benlloch S; Sánchez-Tejada L; Adrover E; Lerma E; Peiró FM; Sánchez-Payá J; Aranda FI
    Breast Cancer Res Treat; 2009 Sep; 117(2):433-41. PubMed ID: 18683043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.
    Yang XR; Charette LA; Garcia-Closas M; Lissowska J; Paal E; Sidawy M; Hewitt SM; Rimm DL; Sherman ME
    Diagn Mol Pathol; 2006 Sep; 15(3):157-61. PubMed ID: 16932071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaussian Mixture Models for Probabilistic Classification of Breast Cancer.
    Prabakaran I; Wu Z; Lee C; Tong B; Steeman S; Koo G; Zhang PJ; Guvakova MA
    Cancer Res; 2019 Jul; 79(13):3492-3502. PubMed ID: 31113820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
    Sarfstein R; Nagaraj K; LeRoith D; Werner H
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.
    Wetstein SC; Onken AM; Luffman C; Baker GM; Pyle ME; Kensler KH; Liu Y; Bakker B; Vlutters R; van Leeuwen MB; Collins LC; Schnitt SJ; Pluim JPW; Tamimi RM; Heng YJ; Veta M
    PLoS One; 2020; 15(4):e0231653. PubMed ID: 32294107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
    Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
    Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
    Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
    BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
    Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
    Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Hypertension and a Commonly Inherited IGF1R Variant (rs2016347) Reduce Breast Cancer Risk by Enhancing Mammary Gland Involution.
    Powell MJ; Dufault SM; Henry JE; Allison AC; Cora R; Benz CC
    J Oncol; 2019; 2019():6018432. PubMed ID: 31687025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
    Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
    Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
    Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
    Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
    Beca F; Kensler K; Glass B; Schnitt SJ; Tamimi RM; Beck AH
    Breast Cancer Res; 2017 Mar; 19(1):21. PubMed ID: 28253895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study.
    McLaren BK; Gobbi H; Schuyler PA; Olson SJ; Parl FF; Dupont WD; Page DL
    Am J Surg Pathol; 2005 Jan; 29(1):105-8. PubMed ID: 15613861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients.
    Hernandez BY; Wilkens LR; Le Marchand L; Horio D; Chong CD; Loo LW
    Cancer Med; 2015 Mar; 4(3):354-62. PubMed ID: 25619494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.
    Farabaugh SM; Litzenburger BC; Elangovan A; Pecar G; Walheim L; Atkinson JM; Lee AV
    Dev Biol; 2020 Jul; 463(1):77-87. PubMed ID: 32376245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.